- Report
- October 2024
- 188 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- January 2025
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2025
- 191 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Clinical Trials
- June 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- July 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- January 2025
- 150 Pages
United States
From €5656EUR$5,950USD£4,752GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- January 2025
- 142 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- August 2024
- 220 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- June 2024
- 104 Pages
United States
From €1854EUR$1,950USD£1,557GBP
- Report
- August 2022
United States
From €1844EUR$1,940USD£1,549GBP
- Report
- August 2022
Global
From €941EUR$990USD£791GBP
- Report
- August 2021
Global
From €3793EUR$3,990USD£3,187GBP
- Drug Pipelines
- August 2022
- 60 Pages
Global
From €1188EUR$1,250USD£998GBP
- Report
- January 2024
- 143 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- August 2024
- 80 Pages
Japan
From €3327EUR$3,500USD£2,795GBP
- Report
- January 2022
- 200 Pages
Global
From €7130EUR$7,500USD£5,990GBP

The Endometriosis Drug market is a subset of the Immune Disorders Drugs market. Endometriosis is a condition in which the tissue that normally lines the uterus grows outside of the uterus, causing pain and other symptoms. Endometriosis drugs are used to treat the symptoms of endometriosis, such as pain, heavy menstrual bleeding, and infertility. These drugs can be divided into two categories: hormonal therapies and non-hormonal therapies. Hormonal therapies include oral contraceptives, progestins, and gonadotropin-releasing hormone agonists. Non-hormonal therapies include non-steroidal anti-inflammatory drugs, danazol, and GnRH antagonists.
Some companies in the Endometriosis Drug market include AbbVie, Allergan, Bayer, Merck, and Pfizer. Show Less Read more